Teva Pharmaceutical Industries Ltd (TEVA)
18.64
+0.19
(+1.03%)
USD |
NYSE |
Nov 04, 16:00
18.79
+0.15
(+0.80%)
After-Hours: 20:00
Teva Pharmaceutical Industries Profit Margin (Quarterly): -20.32% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -20.32% |
| March 31, 2024 | -3.64% |
| December 31, 2023 | 9.63% |
| September 30, 2023 | 2.08% |
| June 30, 2023 | -22.49% |
| March 31, 2023 | -6.01% |
| December 31, 2022 | -33.84% |
| September 30, 2022 | 1.56% |
| June 30, 2022 | -6.13% |
| March 31, 2022 | -26.09% |
| December 31, 2021 | -3.88% |
| September 30, 2021 | 7.51% |
| June 30, 2021 | 5.29% |
| March 31, 2021 | 1.93% |
| December 31, 2020 | 3.37% |
| September 30, 2020 | -109.3% |
| June 30, 2020 | 3.62% |
| March 31, 2020 | 1.58% |
| December 31, 2019 | 2.44% |
| September 30, 2019 | -7.67% |
| June 30, 2019 | -16.50% |
| March 31, 2019 | -2.53% |
| December 31, 2018 | -72.59% |
| September 30, 2018 | -4.59% |
| June 30, 2018 | -3.74% |
| Date | Value |
|---|---|
| March 31, 2018 | 22.11% |
| December 31, 2017 | -237.1% |
| September 30, 2017 | 10.59% |
| June 30, 2017 | -104.4% |
| March 31, 2017 | 11.42% |
| December 31, 2016 | -14.99% |
| September 30, 2016 | 7.41% |
| June 30, 2016 | 5.04% |
| March 31, 2016 | 13.22% |
| December 31, 2015 | 10.24% |
| September 30, 2015 | 2.14% |
| June 30, 2015 | 10.85% |
| March 31, 2015 | 8.95% |
| December 31, 2014 | 13.29% |
| September 30, 2014 | 17.32% |
| June 30, 2014 | 14.83% |
| March 31, 2014 | 14.88% |
| December 31, 2013 | 7.00% |
| September 30, 2013 | 14.05% |
| June 30, 2013 | -9.18% |
| March 31, 2013 | 12.85% |
| December 31, 2012 | 6.10% |
| September 30, 2012 | -1.59% |
| June 30, 2012 | 17.28% |
| March 31, 2012 | 16.84% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-109.3%
Minimum
Sep 2020
9.63%
Maximum
Dec 2023
-10.14%
Average
1.56%
Median
Sep 2022
Profit Margin (Quarterly) Benchmarks
| Amicus Therapeutics Inc | -12.39% |
| Compugen Ltd | -31.68% |
| Pluri Inc | -5.97K% |
| Can Fite Biofarma Ltd | -1.07K% |
| BiomX Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -6.36% |
| Return on Assets | -1.12% |
| Return on Invested Capital | -1.75% |
| Gross Profit Margin (Quarterly) | 48.61% |
| Operating Margin (Quarterly) | 19.60% |
| Return on Net Operating Assets | -1.24% |